New U.S. Rules On Risky Pathogen Research Draw Mixed Reviews [7]
"A new U.S. policy that aims to reduce the risks arising from federally funded research with dangerous pathogens is drawing mixed reviews from scientists, with even some who support tighter regulation fearing its vague wording could complicate, not clarify, the rules on what kinds of studies the government will support."
